Loading…
Back To Schedule
Monday, June 19 • 8:30am - 10:00am
#103: The Future of Patient Engagement: Measuring What Matters

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Feedback form is now closed.
Component Type: Session
Level: Intermediate
CE: ACPE 1.50 Knowledge UAN: 0286-0000-17-568-L04-P; CME 1.50; IACET 1.50; RN 1.50

As awareness and theory around patient engagement in the medical product life cycle have matured, stakeholders are now focusing on best practices and implementation of patient centric strategies. In this session, patient, industry, and regulatory stakeholders will share their perspectives on today’s meaning of effective engagement and what the future state of patient engagement will look like. Panelists will discuss what they believe should be the outcomes of their investments of effort and how we can engage patients to identify the outcomes that matter most. The idea of “return on engagement” will be explored: how do we measure what matters? How do we turn insights into regulatory utilities? And how do we capture the return – to drug and device development – on this investment in patient engagement?

Join Patient Engagement Community for a follow up Round Table discussion at 12:30pm in the Community Corner.

Learning Objectives

Describe the meaning of effective patient engagement and where it should take place during the medical product life cycle; Discuss approaches to involving patients in the determination of meaningful outcomes throughout the life cycle of medical therapies; Identify potential measures that could demonstrate the return on meaningful engagement for patient, regulatory, and industry stakeholders. Explore patient engagement in today’s policy environment and in the context of global harmonization.

Chair

Debra Lappin, JD

Speaker

Panelist
Anne C. Beal, MD, MPH

Panelist
Juan Garcia-Burgos, MD

Panelist
K. Kimberly McCleary

Panelist
Paul Kluetz, MD

Panelist
Ronald Joseph Bartek, MA


Speakers
avatar for Ronald Bartek

Ronald Bartek

Co-Founder/Founding President, Friedreich's Ataxia Research Alliance (FARA)
Co-founder/President, FARA, Board of Directors, NORD; NIH/NINDS National Advisory Council; partner/president, government affairs firm; 20 yrs federal service in defense, foreign policy & intelligence; U.S. Delegation to Intermediate-Range Nuclear Forces (INF) Treaty talks, Geneva... Read More →
avatar for Anne Beal

Anne Beal

Senior VP, Chief Patient Officer and Global Head of Patient Centricity, Sanofi
Dr. Anne C. Beal, is the Chief Patient Officer at Sanofi. She is responsible for integrating the patient voice and priorities into all aspects of Sanofi’s work to facilitate development of healthcare solutions that truly meet patients’ needs. Dr. Beal joined Sanofi from PCORI... Read More →
avatar for Juan Garcia-Burgos

Juan Garcia-Burgos

Head of Public Engagement Department, European Medicines Agency (EMA)
Juan Garcia Burgos is Head of Public Engagement Department and Co-chair of the EMA patients’ & healthcare professionals’ working parties. He is a Medical Doctor specialised in urology. In 2002 he joined the EMA to coordinate the preparation of EU clinical guidelines for drug development... Read More →
avatar for Paul Kluetz

Paul Kluetz

Associate Director for Patient Outcomes (Acting), OCE, FDA
Paul G. Kluetz, M.D., is a medical oncologist and the Acting Associate Director of Patient Outcomes in the Oncology Center of Excellence at the U.S. FDA. He is interested in defining clinical benefit in oncology trials, the use of expedited programs such as accelerated approval and... Read More →
avatar for Debra Lappin

Debra Lappin

Head, Health Biosciences Practice, FaegreBD Consulting
Debra Lappin serves as a principal with Faegre Baker Daniels Consulting, where she leads the health and biosciences team, and as counsel with Faegre Baker Daniels. She consults with public, private and nonprofit entities across the life science sector and is a creative force in forging... Read More →
avatar for K. Kimberly McCleary

K. Kimberly McCleary

Managing Director, FasterCures, A Center of the Milken Institute
Kim leads the Patients Count: Science of Patient Input program through which FasterCures aims to improve health by expanding opportunities for patients’ perspectives to shape the processes by which new therapies are discovered, developed and delivered. She has been involved in FasterCures... Read More →

Monday June 19, 2017 8:30am - 10:00am CDT
S100c McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  12: DIAmond, Session
  • format json
  • Featured Topics Patient Centric ,Clinical Operations,Wearables-Mobile Health,StudentProgramming
  • Credit Type ACPE, CME, IACET, RN
  • Tags Session